Literature DB >> 19497686

Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6.

Kirsten M Raehal1, Cullen L Schmid, Ivan O Medvedev, Raul R Gainetdinov, Richard T Premont, Laura M Bohn.   

Abstract

G protein-coupled receptor kinases (GRKs) are a family of intracellular proteins that desensitize and regulate the responsiveness of G protein-coupled receptors (GPCRs). In the present study, we assessed the contribution of GRK6 to the regulation and responsiveness of the G protein-coupled mu-opioid receptor (microOR) in response to morphine in vitro and in vivo using mice lacking GRK6. In cell culture, overexpression of GRK6 facilitates morphine-induced beta-arrestin2 (betaarrestin2) recruitment and receptor internalization, suggesting that this kinase may play a role in regulating the microOR. In vivo, we find that acute morphine treatment induces greater locomotor activation but less constipation in GRK6 knockout (GRK6-KO) mice compared to their wild-type (WT) littermates. The GRK6-KO mice also appear to be "presensitized" to the locomotor stimulating effects induced by chronic morphine treatment, yet these animals do not display more conditioned place preference than WT mice do. Furthermore, several other morphine-mediated responses which were evaluated, including thermal antinociception, analgesic tolerance, and physical dependence, were not affected by ablation of the GRK6 gene. Collectively, these results suggest that GRK6 may play a role in regulating some, but not all morphine-mediated responses. In addition, these findings underscore that the contribution of a particular regulatory factor to receptor function can differ based upon the specific cell composition and physiology assessed, and illustrate the need for using caution when interpreting the importance of interactions observed in cell culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497686      PMCID: PMC2771341          DOI: 10.1016/j.drugalcdep.2009.04.011

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  41 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain.

Authors:  M Erdtmann-Vourliotis; P Mayer; S Ammon; U Riechert; V Höllt
Journal:  Brain Res Mol Brain Res       Date:  2001-11-01

4.  Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.

Authors:  M A Hurlé
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

5.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

6.  Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.

Authors:  Francoise Rouge-Pont; Alessandro Usiello; Marianne Benoit-Marand; Francois Gonon; Pier Vincenzo Piazza; Emiliana Borrelli
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

8.  An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.

Authors:  C E Groer; K Tidgewell; R A Moyer; W W Harding; R B Rothman; T E Prisinzano; L M Bohn
Journal:  Mol Pharmacol       Date:  2006-11-07       Impact factor: 4.436

9.  G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Authors:  Gregory W Terman; Wenzhen Jin; Young-Pyo Cheong; Janet Lowe; Marc G Caron; Robert J Lefkowitz; Charles Chavkin
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

10.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more
  20 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 2.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

3.  GIRK channel modulation by assembly with allosterically regulated RGS proteins.

Authors:  Hao Zhou; Mariangela Chisari; Kirsten M Raehal; Kevin M Kaltenbronn; Laura M Bohn; Steven J Mennerick; Kendall J Blumer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

4.  Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activation.

Authors:  Tanya L Daigle; Marc G Caron
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 5.  G protein-coupled receptor kinases as regulators of dopamine receptor functions.

Authors:  Eugenia V Gurevich; Raul R Gainetdinov; Vsevolod V Gurevich
Journal:  Pharmacol Res       Date:  2016-05-10       Impact factor: 7.658

6.  The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Neuropharmacology       Date:  2010-08-14       Impact factor: 5.250

7.  Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus.

Authors:  J Drgonova; D B Zimonjic; F S Hall; G R Uhl
Journal:  Neuroscience       Date:  2009-10-09       Impact factor: 3.590

8.  Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.

Authors:  Laura Glück; Anastasia Loktev; Lionel Moulédous; Catherine Mollereau; Ping-Yee Law; Stefan Schulz
Journal:  Biol Psychiatry       Date:  2014-02-03       Impact factor: 13.382

9.  Disruption of dopamine D1 receptor phosphorylation at serine 421 attenuates cocaine-induced behaviors in mice.

Authors:  Ying Zhang; Ning Wang; Ping Su; Jie Lu; Yun Wang
Journal:  Neurosci Bull       Date:  2014-10-10       Impact factor: 5.203

10.  Development of functionally selective, small molecule agonists at kappa opioid receptors.

Authors:  Lei Zhou; Kimberly M Lovell; Kevin J Frankowski; Stephen R Slauson; Angela M Phillips; John M Streicher; Edward Stahl; Cullen L Schmid; Peter Hodder; Franck Madoux; Michael D Cameron; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.